{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T20:37:17Z","timestamp":1715632637912},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,7,15]]},"DOI":"10.1093\/ajhp\/54.14.1578","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T15:47:26Z","timestamp":1550764046000},"page":"1578-1578","source":"Crossref","is-referenced-by-count":4,"title":["FDA proposes constraints on ephedrine dietary supplements"],"prefix":"10.1093","volume":"54","member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/54\/14\/1578\/28395543\/ajhp1578.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T08:40:18Z","timestamp":1555144818000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/54\/14\/1578\/5154689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7,15]]},"references-count":0,"journal-issue":{"issue":"14","published-print":{"date-parts":[[1997,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/54.14.1578","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,7,15]]},"published":{"date-parts":[[1997,7,15]]}}}